Wednesday, October 5, 2011

Bio-Rad buys digital PCR developer QuantaLife for $162M

Life sciences research and diagnostics equipment developer Bio-Rad Laboratories Inc. bought QuantaLife Inc. for at least $162 million cash, the company said Wednesday.
QuantaLife, based in Pleasanton, has developed a system for digital PCR, or polymerase chain reaction, that can help detect rare mutations.

No comments:

Post a Comment